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Several proteins with an affinity to RNA contain a conserved sequence of 8 amino acids which is postulated as being 
important for RNA binding. An oligopeptide of 11 amino acids containing this sequence is shown to bind 32P-labelled 
globin mRNA in a filter binding assay. High concentrations of heparin compete for this binding. 10 other peptides with 
different sequences do not exhibit affinity to RNA in this assay. These results support the relevance of the conserved 
peptide sequence in the binding of proteins to RNA. 
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1. INTRODUCTION 
RNA is found in eukaryotic cells in association 
with specific proteins to form ribonucleoprotein 
(RNP) complexes [I]. The RNA-binding proteins 
are likely to be involved in RNA biogenesis, 
metabolism and function [I]. Sequence informa- 
tion obtained from the cloning of RNP proteins 
revealed a highly conserved octapeptide sequence 
situated in a domain of roughly 100 amino acids 
which is reiterated up to four times in single pro- 
tein species [2]. This conserved octapeptide se- 
quence has been observed in RNA-binding 
proteins from yeast, plants, insects and mammals 
and has been named ‘RNP 1’ [ 121 or ‘RNP-CS’ [3]. 
Recent studies on the poly(A)-binding protein of 
yeast and the mammalian hnRNP protein Al sug- 
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gest that this sequence might be essential for RNA 
binding [2-81. 
In this study, we have investigated the binding of 
globin mRNA to a synthetic oligopeptide of 11 
amino acids containing the RNPl consensus se- 
quence (table 1) from the fourth domain of the 
yeast poly(A)-binding protein [4], in which cys- 
teine in the highly variable position of the octapep- 
tide sequence was replaced by serine, and tyrosine 
was added at the COOH-terminus. Our results 
show that the RNPl oligopeptide binds to globin 
mRNA in a heparin-sensitive manner and that 
oligopeptides with a different amino acid composi- 
tion, though containing up to four lysine residues, 
do not exhibit RNA-binding activity. 
2. MATERIALS AND METHODS 
2.1. Preparation of peptides 
Peptides were synthesized with a Labortec Peptide Syn- 
thesizer by M. Hassauer (Institut fur Immunobiologie, Univer- 
sit&t Freiburg). 
2.2. Preparation and labelling of purified globin mRNA 
Globin mRNA from rabbit reticulocyte lysate was prepared 
from salt-washed polysomes by the guanidinium-HCl extrac- 
tion method and subsequent oligo(dT)-cellulose chromatog- 
raphy according to Aviv and Leder [9]. Further purification was 
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performed by gel filtration on a Sephacryl S400 column as 
described by Safer et al. [lo]. 3 ‘-end labelling of mRNA with 
T4 RNA ligase (Pharmacia) was performed as described by 
England et al. [ll] using 5 pg globin mRNA and SO&i 
[3zP]pCp (3000 Ci/mmol; Amersham) in a total reaction 
volume of 30~1. 
2.3. Assay for binding of oligopeptides to mRNA 
Peptides were incubated with 32P-labelled globin mRNA (2 x 
lo4 Cerenkov cpm) in binding buffer (10 mM Tris-HCl, pH 7.2, 
140 mM KCI, 3 mM MgC12, 1 mM EDTA) in a total reaction 
volume of 50 pl for 60 min on ice. For competition experiments 
the competitor was added after 60 min of incubation and the 
samples were incubated for a further 20 min. Samples were 
filtered through a NC membrane (BA 83; Schleicher & Schuell) 
in a dot-blot apparatus. The NC filter was rinsed immediately 
twice with 500~1 of binding buffer in the dot-blot apparatus, 
and subsequently washed three times for 15 min in 50 ml 
binding buffer at room temuerature. air dried and 
autoradiographed. 
3. RESULTS AND DISCUSSION 
When 32P-labelled globin mRNA 
under physiological ionic conditions, 
is incubated 
i.e. 140 mM 
KC1 and 2 mM MgClz, with increasing amounts of 
the oligopeptide containing the RNPl consensus 
sequence (table 1) and subsequently applied to a 
NC filter, the mRNA is retained on the filter in the 
presence of a 30-300-fold molar excess of the 
oligopeptide (fig.1). This result shows that an 
RNPl containing peptide has RNA-binding activi- 
ty and, therefore, might be responsible for the 
binding of protein fragments of RNP proteins to 
ssDNA-agarose or poly(ethenoadenylate) [5,6]. In 
order to test the specificity of the amino acid se- 
quence of the RNPl oligopeptide for mRNA bin- 
ding, we performed the binding assay with 10 
oligopeptides of different amino acid compositions 
(table 1) derived from the SV40 large T antigen 
[12]. As fig.2 shows that none of them is capable 
of binding mRNA in the range of 30-200-fold 
molar excess, despite the fact that two of them 
(peptide 1 and 2) are reported to have affinity to 
DNA [12]. The retention of RNA on NC filters in 
the presence of the RNPl oligopeptide is also not 
due to its greater affinity to NC compared to the 
other oligopeptides since amidoblack staining in- 
dicates that all peptides are retained in comparable 
amounts on the filter (data not shown). The rever- 
sibility of the binding of RNPl oligopeptide to 
labelled globin mRNA is indicated by the ability of 
unlabelled globin mRNA to compete for this 
Table 1 
Sequences of the peptides used in this study 
Peptide Sequence 
1 Ser-Glu-Glu-Met-Pro-Ser-Ser-Asp-Tyr 
2 Gin-His-Ser-Thr-Pro-Pro-Lys-Tyr 
3 Gln-His-Ser-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val 
4 Thr-Thr-Lys-Glu-Lys-Ala-Ala-Leu-Leu-Tyr-Lys- 
Lys-Ile-Met-Glu-Tyr 
5 Ile-Ser-Arg-His-Asn-Ser-Tyr 
6 Ser-His-Tyr-Lys-Tyr-His-Glu 
7 Asp-Val-Lys-Gly-Thr-Gly-Gly-Glu-Ser-Tyr 
8 Lys-His-Leu-Asn-Lys-Arg-Thr-Gln-Ile-Tyr 
9 Ala-Pro-Gln-Ser-Ser-Gln-Ser-Val-Tyr 
10 Lys-Pro-Pro-Thr-Pro-Pro-Glu-Pro-Thr 
P Ser-Lys-Gly-Phe-Gly-Phe-Val-Ser-Phe-Ser-Tyr 
LYS Phe Gly Phe Phe 
Consensus ArgGly-Tyr-Val-Tyr-Val- X -Tyr 
Peptides l-10 are derived from the SV40 large T antigen. P 
indicates the RNPl oligopeptide derived from the fourth 
domain of the yeast poly(A)-binding protein and modified as 
described in the text. Consensus indicates the consensus 
sequence RNPl. Variable positions are indicated by the two 
possible amino acids or with ‘X’ for any amino acid 
binding when it is added after one hour of incuba- 
tion (data not shown). 
The minimal size, however, has a certain impact 
on the RNA-binding capability of the RNPl 
oligopeptide. Obviously, more than one molecule 
of oligopeptide is necessary for binding and/or 
retention of one molecule of labelled mRNA on 
the NC filter (fig.1). Furthermore, heparin com- 
petes with the oligopeptide in its interaction with 
mRNA. High concentrations (125fold molar ex- 
cess over mRNA) of this polyanion drastically 
reduce the amount of filter-bound labelled mRNA 
in the presence of the RNPl oligopeptide (fig.3). 
The heparin sensitivity of the binding of the 
oligopeptide observed here is somewhat in contrast 
to the data obtaind for hnRNP proteins [ 131 or the 
yeast poly(A)-binding protein [14] which has been 
reported to bind to ssDNA or ribonucleotide 
homopolymers in a heparin-resistant manner. The 
lack of surrounding amino acid sequences in the 
RNPl oligopeptide is likely to account for this 
fact. 
One of the most striking features of the RNPl 
oligopeptide is the positively charged amino acid 
lysine followed by an alternating sequence of 
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Fig. 1. Concentration-dependent binding of RNPl oligopeptide 
to globin mRNA. 2 x 104 Cerenkov cpm “P-1abelled globin 
mRNA (0.025 pmol) were incubated with RNPl oligopeptide in 
the indicated molar excess over mRNA in binding buffer for 
60 min on ice. The samples were filtered through NC 
membranes. The autoradiograph of the NC filter is shown. 
aromatic and small amino acids (table 1). It was 
postulated that this amino acid sequence is capable 
of RNA binding by two cooperating mechanisms: 
(i) the ionic interaction between the lysine residue 
and the phosphate backbone of the RNA; (ii) the 
intercalation of the aromatic residues between the 
nucleotide bases which is probably facilitated by 
the neighbouring small amino acids allowing 
freedom of movement [ 15-181. Basic or aromatic 
residues which are not in the suitable context, as is 
the case for the peptides l-10 (table l), do not pro- 
mote RNA binding in contrast to those in the 
RNPl oligopeptide (fig.2). 
The data presented here support the relevance of 
the RNPl consensus sequence for the RNA- 
binding activity of proteins. It is, however, pro- 
bably not the only RNA-binding motif of these 
proteins, since a recent study has shown that its 
deletion or mutation in the yeast poly(A)-binding 
protein results only in a retardation but not in an 
arrest of growth [19], though an in vivo com- 
plementation by other proteins for the poly(A)- 
binding protein deficiency has not been ruled out 
Fig.2. Concentration-dependent binding of 11 oligopeptides to 
globin mRNA. Symbols correspond to table 1, conditions to 
fig.1. 
Fig.3. Competition of the binding of RNPl oligopeptide to 
globin mRNA by heparin. 2 x lo4 Cerenkov cpm “P-1abelled 
globin mRNA (0.025 pmol) were incubated with 5 pmol 
(200-fold molar excess) RNPl oligopeptide in binding buffer 
for 60 min on ice. Then heparin in the indicated molar excess 
over mRNA was added and incubation was continued for 
20 min. The samples were filtered through NC membranes. The 
autoradiograph of the NC filter is shown. C, no peptide, no 
heparin. 
in this case. Further experimental work is in pro- 
gress to elucidate the role of the RNPl sequence in 
naturally occurring RNP proteins, e.g. by means 
of antibodies raised to carrier protein-linked RNPl 
oligopeptide. 
Acknowledgements: This work was supported by a grant from 
the Deutsche Forschungsgemeinschaft (Hi 18813-4). We like to 
thank R. Bandziulis for providing us with a manuscript prior to 
publication. 
REFERENCES 
111 
121 
131 
141 
VI 
161 
171 
PI 
191 
[lOI 
1111 
WI 
u31 
Dreyfuss, G. (1986) Annu. Rev. Cell Biol. 2, 459-498. 
Dreyfuss, G., Swanson, M.S. and Pinol-Roma, S. (1988) 
Trends Biol. Sci. 13, 86-91. 
Bandziulis, R.J., Swanson, M.S. and Dreyfuss, G. (1989) 
Genes Dev., in press. 
Adam, S.A., Nakagawa, T., Swanson, M.S., Woodruff, 
T.K. and Dreyfuss, G. (1986) Mol. Cell. Biol. 6, 
2932-2943. 
Cobianchi, F., Karpel, R.L., Williams, K.R., Notario, V. 
and Wilson, S.H. (1988) J. Biol. Chem. 263, 1063-1071. 
Merril, B.M., Stone, K.L., Cobianchi, F., Wilson, S.H. 
and Williams, K.R. (1988) J. Biol. Chem. 263, 
3307-3313. 
Cobianchi, F., SenGupta, D.N., Zmudzka, B.Z. and 
Wilson, S.H. (1986) J. Biol. Chem. 261, 3536-3543. 
Williams, K.R., Stone, K.L., Lopresti, M.B., Merril, 
B.M. and Planck, S. (1985) Proc. Natl. Acad. Sci. USA 
82, 5666-5670. 
Aviv, H. and Leder, P. (1972) Proc. Natl. Acad. Sci. USA 
69, 1408-1412. 
Safer, B., Jagus, R. and Kemper, W.M. (1979) Methods 
Enzymol. 60, 61-87. 
England, T.E., Bruce, A.G. and Uhlenbeck, O.C. (1980) 
Methods Enzymol. 65, 65-74. 
Friedrich, V., Scheidtmann, K.-H. and Walter, G. (1986) 
Immunol. Lett. 12, 207-215. 
Pinol-Roma, S., Choi, Y.D., Matunis, M.J. and 
Dreyfuss, G. (1988) Genes Dev. 2, 215-227. 
119 
Volume 251, number 1,2 FEBS LETTERS July 1989 
[14] Swanson, M.R. and Dreyfuss, G. (1988) Mol. Cell. Biol. 
8, 2237-2241. 
[15] Prigodich, R.V., Shamoo, Y., Williams, K.R., Chase, 
J.W., Konigsberg, W.H. and Colemann, J.E. (1986) 
Biochemistry 25, 3666-3672. 
[la] Bugler, B., Bourbon, H., Lapeyre, B., Wallace, M.O., 
Chang, J.H., Almaric, F. and Olson, O.J. (1987) J. Biol. 
Chem. 262, 10922-10925. 
[17] Helene, C. and Maurizot, J.-C. (1981) Cr. Rev. Biochem. 
10, 213-258. 
[18] Chase, J.W. and Williams, K.R. (1986) Annu. Rev. 
Biochem. 55, 103-136. 
[19] Sachs, A.B., Davis, R.W. and Kornberg, R.D. (1987) 
Mol. Cell. Biol. 9, 3268-3276. 
120 
